The Trump administration is preparing to announce an expansion of its TrumpRx prescription drug initiative, according to reporting from multiple outlets. The expansion is expected to broaden TrumpRx’s direct-to-consumer offerings as part of the administration’s broader effort to lower prescription-drug costs. Bloomberg reports that the administration is adding generic medications to the TrumpRx website. Bloomberg also says Mark Cuban, a prominent entrepreneur and adviser, is expected to attend the White House rollout on Monday afternoon, based on information from people familiar with the plan. The New York Post similarly reports that Cuban is set to join President Donald Trump at the White House event tied to the expanded TrumpRx initiative. Both accounts frame the announcement as an administration move to expand access to lower-cost drugs through the TrumpRx platform. Specific details about which medications are included, the timeline for availability, and how the expansion will work for consumers are not fully described in the provided reports.